Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Pediatric demyelinating diseases.
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
Autonomic Dysregulation in Multiple Sclerosis.
Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.
Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability.
FDA reversal sends mixed message to multiple sclerosis community.
Unmasking and provoking severe disease activity in a patient with NMO spectrum disorder.
Remyelination in multiple sclerosis: realizing a long-standing challenge.
Neuroinflammation: The Devil is in the Details.
Interferon-beta-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report.
Early detection of thrombin activity in neuroinflammatory disease.
St. John's wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells.
Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.
Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis?
Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria.
CXCL10 Triggers Early Microglial Activation in the Cuprizone Model.
Immune surveillance of the central nervous system in multiple sclerosis - Relevance for therapy and experimental models.
Anxiety, depression and impaired health-related quality of life are therapeutic challenges in patients with multiple sclerosis.
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases.
Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI.
A Longitudinal Examination of the Hopelessness Theory of Depression in People Who Have Multiple Sclerosis.
Implications for multiple sclerosis in the era of the Affordable Care Act: a clinical overview.
Vitamin D During Pregnancy and Multiple Sclerosis: An Evolving Association.
Implanting glass spinal cord windows in adult mice with experimental autoimmune encephalomyelitis.
Repair strategies for multiple sclerosis: challenges, achievements and perspectives.
Pages
« first
‹ previous
…
522
523
524
525
526
527
528
529
530
…
next ›
last »